The threat of antibiotic resistance is growing—fast. Each year, the number of U.S. deaths from resistance is equivalent to a jumbo jet-full of people crashing every week, notes Ankit Mahadevia of Spero Therapeutics.
Mahadevia describes the helpless feeling of seeing patients with infections that don’t respond to any available antibiotics. He also underscores the importance of recent, incremental policy changes that support antibiotic innovation and emphasizes the need to do more.
© The Pew Charitable Trusts